Derakhshan Behrad
Chief Business Officer
Derakhshan Behrad has filed 1 SEC Form 4 filing (6 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.
On the most recent filing, Derakhshan Behrad is listed as Chief Business Officer at Edgewise Therapeutics, Inc. Inside the rolling window, Derakhshan Behrad reported no open-market purchases and 1 open-market sale totaling $223K in EWTX.
Companies traded
Other insiders at EWTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$223K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Derakhshan Behrad made?
Derakhshan Behrad has filed 1 SEC Form 4 filing (6 transaction rows) across 1 company since 2026.
Which companies does Derakhshan Behrad trade?
Derakhshan Behrad has filed SEC Form 4 disclosures for 1 company, including EWTX.
When was Derakhshan Behrad's most recent SEC Form 4 filing?
Derakhshan Behrad's most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.
What is Derakhshan Behrad's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Derakhshan Behrad is listed as Chief Business Officer.
What is Derakhshan Behrad's total buy and sell value in the current window?
Inside the rolling retention window, Derakhshan Behrad bought $0 and sold $223K based on SEC Form 4 filings.
What was Derakhshan Behrad's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,100 EWTX shares on 2026-08-12, worth $223K, per SEC Form 4 filings.